NCI National Clinical Trials Network (NCTN) Program Guidelines

More documents

Recommendations

Info

PART 4: Appendices Section V – Important Definitions, Abbreviations, & NIH/NCI URLs V. Other Important NCI/NIH URLs, Federal Citations, and List of Abbreviations A listing of important URLs (links to websites) and abbreviations referenced in the text of these Guidelines is provided below. A. Website URLs referenced in these Guidelines NCI Website http://www.cancer.gov/ NCI Biomarker, Imaging, and Quality of Life Studies Funding Program (BIQSFP) http://biqsfp.cancer.gov/ NCI Cancer Trials Support Unit (CTSU) Website http://www.ctsu.org NCI Cancer Diagnosis Program’s Request for an Application (RFA) on Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-017.html NCI Cancer Diagnosis Program’s Website http://cdp.cancer.gov/ NCI Center for Coordinating Clinical Trials http://ccct.cancer.gov/about/overview NCI Central IRB Website http://www.ncicirb.org NCI Clinical Trials and Translational Research Advisory Committee (CTAC) http://ccct.cancer.gov/committees/ctac NCI Clinical and Translational Research Operations Committee http://ccct.cancer.gov/committees/ctroc NCI CTWG Steering Committee System (Information on NCI Scientific Steering Committees) http://transformingtrials.cancer.gov/steering/overview NCI Clinical Trials Reporting Program (CTRP) http://www.cancer.gov/clinicaltrials/conducting/ncictrp/main/allpages NCI Guide to Readers to Information on Other NCI Divisions/Branches http://www.cancer.gov/aboutnci Diagnostics Evaluation Branch (DRB) of the Cancer Diagnosis Program (CDP) Program for the Assessment of Clinical Cancer Tests (PACCT) – Clinical Tumor Marker Study Guidelines http://www.cancerdiagnosis.nci.nih.gov/diagnostics/advice/guidelines.htm Good Clinical Practice in FDA-Regulated Clinical Trials http://www.fda.gov/oc/gcp/default.htm Page 216 of 241
PART 4: Appendices Section V – Important Definitions, Abbreviations, & NIH/NCI URLs Guidance Document on Inclusion of Manuscripts/Publications in Appendix Material with NIH/NCI Grant Applications http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-053.html NIH Data Sharing Policy http://grants.nih.gov/grants/policy/data_sharing NIH Freedom of Information Act Office http://www.nih.gov/icd/od/foia/index.htm NIH Grants Policy Statement http://grants.nih.gov/grants/policy/policy.htm NIH Grant Policy for Program Income http://grants.nih.gov/grants/policy/nihgps_2011/nihgps_ch8.htm#_Program_Income NIH Guide Notice on NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research (Amendment October 2001). http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html NIH Public Access Policy (and Manuscript Submission System) http://publicaccess.nih.gov NIH Policy and Guidelines on the Inclusion of Children as Participants in Research Involving Human Subjects (3/6/98) http://www.nih.gov/grants/guide/notice-files/not98-024.html NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research – Amended, October, 2001 (COMPLETE COPY OF UPDATED GUIDELINES) http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm NIH Policy and Guidelines on the Inclusion of Children as Participants in Research Involving Human Subjects – Policy Implementation http://grants.nih.gov/grants/funding/children/children.htm NIH Policy for Data and Safety Monitoring http://grants.nih.gov/grants/guide/notice-files/not98-084.html (Further) NIH Guidance on Data and Safety Monitoring for Phase 1 and Phase 2 trials http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-038.html NIH Policies on Inclusion of Women and Minorities as Participants in Research Involving Human Subjects – Policy Implementation http://grants.nih.gov/grants/funding/women_min/women_min.htm NIH Policy on Financial Conflict of Interest http://grants.nih.gov/grants/policy/coi PHS 398 Grant Application http://grants.nih.gov/grants/funding/phs398/phs398.html PHS 2590 Non-Competing Grant Progress Report http://grants.nih.gov/grants/funding/2590/2590.htm Page 217 of 241
Page 1 and 2:
NATIONAL CANCER INSTITUTE NATIONAL
Page 3 and 4:
NCTN Program Guidelines Table of Co
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
PART 1: Overview of NCTN Program Se
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
PART 1: Overview of the NCTN Progra
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
PART 2: Submission of Competing New
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
PART 2: Submission of New/Competing
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166: PART 2: Submission of New/Competing
Page 187 and 188: PART 3: Submission of Non-Competing
Page 189 and 190: TYPE OF STUDY PART 3: Submission No
Page 191 and 192: PART 3: Submission Non-Competing Ap
Page 193 and 194: PART 3: Submission Non-Competing Ap
Page 195 and 196: PART 4: Appendices Section II - Req
Page 201 and 202: Participating Site Member Category
Page 211 and 212: PART 4: Appendices Section IV - Cos
Page 213 and 214: PART 4: Appendices Section IV - Cos
Page 215: PART 4: Appendices Section IV - Cos
Page 219 and 220: PART 4: Appendices Section V - Impo
Page 221 and 222: PART 4: Appendices Section V - Impo
Page 223 and 224: Part 4: Appendices - VI. Sample Tab
Page 225 and 226: Part 4: Appendices - VII. Model for
Page 227 and 228: Part 4: Appendices - VII. NCTN Prog
Page 233 and 234: Part 4: Appendices - IX. Common Bud
Page 235 and 236: Part 4: Appendices - IX. Common Bud
Page 237 and 238: Part 4: Appendices - VII. Accrual I
Page 239 and 240: Part 4: Summary of Updates to Guide
Page 241: Part 4: Summary of Updates to Guide
show all

NCI National Clinical Trials Network (NCTN) Program Guidelines

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?